Pancreatic acinar cell carcinoma (PAC) is a rare but dismal disease with a peak incidence rate around 60 to 70 years of age. Treatment options in case of metastatic disease are limited and often follo
This project aims to determine the efficacy of our palbociclib-bortezomib clinical trial in mantle cell lymphoma, based on preclinical studies that have shown enhanced killing of MCL and myeloma cells
This zenodo publication corresponds to Janssens et al. 2024. "MLL oncoprotein levels influence leukemia lineage identities." published in Nature Communications. This zenodo publication includes all of
